newsfilter
← Latest News
GlobeNewswire·

Icosavax Granted FDA Fast Track Designation for IVX-A12

SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious